Dear Researchers,

The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Oláh Zsolt Csaba

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2003-2025

2025

Molnár, Z., Babik, B., Csontos, C., Fazakas, J., Gál, J., Hajdú, E. A., Hauser, B. I., Hupuczi, P., Koszta, G., Kupcsulik, S., Matusovits, A., Molnár, C., Mühl, D., Nardai, G., Névery, K. A., Oláh, Z., Smudla, A., Schrick, D. Z., Tánczos, K., Zátroch, I.: A Belügyminisztérium egészségügyi szakmai irányelve az életveszélyes perioperatív vérzések kezeléséről.
Eü. Közl. 75 (13), 1518-1608, 2025.

DEA

Hajdu, E., Molnár, É., Molnárné Rázsó, K., Schlammadinger, Á., Árokszállási, A., Lukács, C. G., Fülesdi, B., Bereczky, Z., Oláh, Z.: A Modified Viscoelastic Point-of-Care Method for Rapid Quantitative Detection of Enoxaparin: a Single-Centre Observational Study.
J Clin Med. 14 (4), 1-13, (article identifier: 1328), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

2024

Kállai, J., Gindele, R., Pénzes-Daku, K., Balogh, G., Kissné Bogáti, R., Bécsi, B., Katona, É., Oláh, Z., Ilonczai, P., Boda, Z., Róna-Tas, Á., Nemes, L., Marton, I., Bereczky, Z.: Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations.
Int. J. Mol. Sci. 25 (5), 1-19, (article identifier: 2893), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

Oláh, Z.: Masszív vérzés.
In: Az intenzív terápia gyakorlata. Szerk.: Mühl Diána, Csontos Csaba, Medicina Könyvkiadó Zrt., Budapest, 201-212, 2024. ISBN: 9789632269153

DEA

Hajdu, E., Berhés, M., László, I., Oláh, Z., Fülesdi, B., Asztalos, L.: Vazopresszin használata szeptikus sokkos betegek ellátásában.
Orv. hetil. 165 (8), 283-290, 2024.

doi DEA Scopus

Journal metrics:

Q4 Medicine (miscellaneous)

2021

Morena-Barrio, M. E., Gindele, R., Bravo-Pérez, C., Ilonczai, P., Zuazu, I., Speker, M., Oláh, Z., Rodríguez-Sevilla, J. J., Entrena, L., Infante, M. S., Morena-Barrio, B., García, J. M., Schlammadinger, Á., Cifuentes-Riquelme, R., Mora, C. A., Miñano, A., Padilla, J., Vicente, V., Corral, J., Bereczky, Z.: High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: description of a new syndrome.
Am. J. Hematol. 96 (11), 1363-1373, 2021.

doi DEA WoS Scopus

Journal metrics:

D1 Hematology

2020

Oláh, Z., Deli, T., Mühl, D.: A Nemzeti Véradó és Vérmentő Program szülészeti vonatkozásai.
Orv. hetil. 161 (37), 1588-1598, 2020.

doi DEA WoS Scopus

Journal metrics:

Q4 Medicine (miscellaneous)

Oláh, Z., Fülesdi, B., Gál, J., Matusovits, A., Babik, B.: A perioperatív vérgazdálkodási program alapelvei.
Orv. hetil. 161 (37), 1554-1568, 2020.

doi DEA WoS Scopus

Journal metrics:

Q4 Medicine (miscellaneous)

2018

Árokszállási, A., Molnárné Rázsó, K., Ilonczai, P., Oláh, Z., Bereczky, Z., Boda, Z., Schlammadinger, Á.: A decade-long clinical experience on the prophylactic use of activated prothrombin complex concentrate in acquired haemophilia A: a case series from a tertiary care centre.
Blood Coagul. Fibrinolysis. 29 (3), 282-287, 2018.

doi DEA

Journal metrics:

Q3 Hematology

Q3 Medicine (miscellaneous)

2017

10.

Selmeczi, A., Gindele, R., Ilonczai, P., Fekete, A., Komáromi, I., Schlammadinger, Á., Molnárné Rázsó, K., Kovács, K. B., Bárdos, H., Ádány, R., Muszbek, L., Bereczky, Z., Boda, Z., Oláh, Z.: Antithrombin Debrecen (p.Leu205Pro): Clinical and molecular characterization of a novel mutation associated with severe thrombotic tendency.
Thromb. Res. 158, 1-7, 2017.

doi DEA WoS Scopus

Journal metrics:

Q2 Hematology

11.

Bereczky, Z., Oláh, Z., Ajzner, É., Kappelmayer, J.: Az új orális antikoagulánsokkal történő kezelés laboratóriumi vonatkozásai.
Orvosi Hetilap. 158 (49), 1930-1945, 2017.

doi DEA WoS Scopus

Journal metrics:

Q4 Medicine (miscellaneous)

12.

Gindele, R., Selmeczi, A., Oláh, Z., Ilonczai, P., Pfliegler, G., Marján, E., Nemes, L., Nagy, Á., Losonczy, H., Mitic, G., Kovac, M., Balogh, G., Komáromi, I., Schlammadinger, Á., Molnárné Rázsó, K., Boda, Z., Muszbek, L., Bereczky, Z.: Clinical and laboratory characteristics of antithrombin deficiencies: a large cohort study from a single diagnostic center.
Thromb. Res. 160, 119-128, 2017.

doi DEA WoS Scopus

Journal metrics:

Q2 Hematology

13.

Kerényi, A., Bekéné Debreceni, I., Oláh, Z., Ilonczai, P., Bereczky, Z., Nagy, B. J., Muszbek, L., Kappelmayer, J.: Evaluation of flow cytometric HIT assays in relation to an IgG-specific immunoassay and clinical outcome.
Cytom. Part B-Clin. Cytom. 92 (5), 389-397, 2017.

doi DEA

Journal metrics:

Q3 Cell Biology

Q2 Histology

Q1 Pathology and Forensic Medicine

2016

14.

Bereczky, Z., Speker, M., Gindele, R., Szabó, Z., Oláh, Z., Pfliegler, G., Kerényi, A., Boda, Z.: Diagnostic issues in antithrombin, protein C and protein S deficiency in the hungarian population: experience of a large thrombosis laboratory.
J. Throm. Haemost. 14 (Suppl.), 98, 2016.

doi DEA WoS

15.

Gindele, R., Oláh, Z., Ilonczai, P., Speker, M., Udvari, Á., Selmeczi, A., Pfliegler, G., Marján, E., Kovács, B., Boda, Z., Muszbek, L., Bereczky, Z.: Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.
J. Thromb. Haemost. 14 (4), 704-715, 2016.

doi DEA WoS Scopus

Journal metrics:

D1 Hematology

D1 Medicine (miscellaneous)

2015

16.

Ilonczai, P., Oláh, Z., Selmeczi, A., Kerényi, A., Bereczky, Z., Póka, R., Schlammadinger, Á., Boda, Z.: Management and outcome of pregnancies in women with antithrombin deficiency: a single-center experience and review of literature.
Blood Coagul. Fibrinolysis. 26 (7), 798-804, 2015.

DEA

Journal metrics:

Q3 Hematology

Q2 Medicine (miscellaneous)

17.

Selmeczi, A., Roach, R. E. J., Móré, C., Batta, Z., Hársfalvi, J., Van de Bom, A., Boda, Z., Oláh, Z.: Thrombin generation and low-molecular-weight heparin prophylaxis in pregnant women with thrombophilia.
Thromb. Haemost. 113 (2), 283-289, 2015.

doi DEA

Journal metrics:

Q1 Hematology

2014

18.

Kovács, B., Bereczky, Z., Selmeczi, A., Gindele, R., Oláh, Z., Kerényi, A., Boda, Z., Muszbek, L.: Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies.
Clin. Chem. Lab. Med. 52 (12), 1797-1806, 2014.

doi DEA

Journal metrics:

Q2 Biochemistry (medical)

Q2 Clinical Biochemistry

Q1 Medicine (miscellaneous)

2013

19.

Oláh, Z., Szarvas, M., Bereczky, Z., Kerényi, A., Kappelmayer, J., Boda, Z.: Direct thrombin inhibitors and factor Xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant.
Arch. Pathol. Lab. Med. 137 (7), 967-973, 2013.

DEA

Journal metrics:

D1 Medical Laboratory Technology

Q1 Medicine (miscellaneous)

Q1 Pathology and Forensic Medicine

20.

Kovács, B., Bereczky, Z., Oláh, Z., Gindele, R., Kerényi, A., Selmeczi, A., Boda, Z., Muszbek, L.: The Superiority of Anti-FXa Assay Over Anti-FIIa Assay in Detecting Heparin-Binding Site Antithrombin Deficiency.
Am. J. Clin. Pathol. 140 (5), 675-679, 2013.

doi DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q1 Pathology and Forensic Medicine

2012

21.

Árokszállási, A., Ilonczai, P., Molnárné Rázsó, K., Oláh, Z., Bereczky, Z., Boda, Z., Schlammadinger, Á.: Acquired haemophilia: an often overlooked cause of bleeding - experience from a Hungarian tertiary care centre.
Blood Coagul. Fibrinolysis. 23 (7), 584-589, 2012.

doi DEA

Journal metrics:

Q2 Hematology

Q2 Medicine (miscellaneous)

22.

Oláh, Z., Kerényi, A., Kappelmayer, J., Schlammadinger, Á., Molnárné Rázsó, K., Boda, Z.: Rapid-onset heparin-induced thrombocytopenia without previous heparin exposure.
Platelets. 23 (6), 495-498, 2012.

doi DEA

Journal metrics:

Q2 Hematology

Q2 Medicine (miscellaneous)

2011

23.